Bridging Borders — The US-Mexico Medical Device Corridor
The San Diego–Tijuana region is much more than a border: it has become what many experts call North America’s medical device manufacturing capital. In this economic corridor, critical components are produced every day for thousands of products that save lives worldwide — from syringes and catheters to high-tech devices requiring precision assembly.
Every day, thousands of parts cross this border. Yet, the journey is not always straightforward. Medical supply chains are often complex, facing regulatory barriers, cultural differences, logistical costs, and the need to comply with strict international certifications. For many manufacturers, taking a medical device from initial design to market means coordinating dozens of players: plastics suppliers, assembly companies, sterilization labs, and regulatory partners. In this context, any delay can mean millions in losses and slower access for patients to new technologies.
This is where Alliance Medical Technologies (AMT) steps in, a company created precisely to build a solid bridge between the United States and Mexico. AMT offers a model that combines the best of both worlds: the trust and protection of a Delaware corporate structure, alongside the strategic advantages of operating just 20 miles south of San Diego, in Baja California.
From this privileged position, AMT has designed a streamlined model that simplifies the entire process. Its offering includes precision plastic injection molding, medical and electronic assembly in ISO-certified cleanrooms, and validated sterilization processes that meet the world’s most demanding standards (FDA, ISO 13485, ISO 14644, ISO 11135, ISO 11137). This integration allows clients to manage their entire manufacturing cycle in one place, without coordinating multiple disconnected suppliers.
AMT also adds a key differentiator: strategic program management. This means we don’t just produce — we facilitate the entire supply chain. We manage commercial transactions, audit internal quality processes (QMS), coordinate corrective and preventive actions (CAPA), and connect companies with the most reliable manufacturers in the sector.
In practice, this translates into efficiency and risk reduction. For example, a U.S. company developing a new device can design its prototype in San Diego, manufacture it through injection molding in Tijuana, assemble it in a certified cleanroom, sterilize it with validated processes, and have it ready for export within weeks. All this with reduced logistics costs, leveraging Mexico’s trade agreements, and under the legal framework of the U.S. that provides global investors with trust.
The visual narrative of this corridor is powerful: trailers crossing the border, binational teams working together, specialized Mexican operators assembling devices in controlled environments, and finally, boxes labeled Made in Mexico heading to hospitals in the U.S., Europe, and Asia.
In conclusion, the San Diego–Tijuana corridor represents a unique opportunity for companies seeking quality, speed, and competitiveness in the medical sector. And at the heart of this ecosystem stands AMT, transforming what was once a fragmented supply chain into an integrated, reliable, and results-driven system.